Home › Funds › 13D Management LLC › EXEL
13D Management LLC position in EXEL
EXELIXIS INC · Health Care
13D Management LLC reported holding 101,335 shares of EXEL (EXELIXIS INC) in its Q2 2026 13F filing — a position valued at US$5.5M, representing 7.73% of its reported portfolio and ranking #8 among its reported holdings. 13D Management LLC has disclosed EXEL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 13D Management LLC's EXEL position evolved
13D Management LLC first disclosed a stake in EXEL in Q3 2023 at 479,728 shares (US$10.5M). Across 12 filings, 13D Management LLC increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 101,335 shares valued at US$5.5M. Notable position changes include a 35% trim in Q4 2023 (shares fell 4% over the following quarter), a 37% trim in Q4 2024 (shares rose 11% over the following quarter), a 35% trim in Q1 2025 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 479.73K | $10.48M | New |
| Q4 2023 | 309.70K | $7.43M | Reduce |
| Q1 2024 | 310.05K | $7.36M | Hold |
| Q2 2024 | 360.01K | $8.09M | Add |
| Q3 2024 | 360.57K | $9.36M | Hold |
| Q4 2024 | 228.61K | $7.61M | Reduce |
| Q1 2025 | 147.51K | $5.45M | Reduce |
| Q2 2025 | 143.34K | $6.32M | Reduce |
| Q3 2025 | 120.33K | $4.97M | Reduce |
| Q4 2025 | 120.33K | $5.27M | Hold |
| Q1 2026 | 101.33K | $4.35M | Reduce |
| Q2 2026 | 101.33K | $5.51M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EXEL and 13F data
EXEL (EXELIXIS INC) is a Health Care company. 42 other funds we track also report a position in EXEL — the largest reported positions include Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M), Renaissance Technologies (US$730.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EXEL
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.47M sh · $732.79M · Q2 2026
- Renaissance Technologies 13.43M sh · $730.62M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.93M sh · $485.85M · Q2 2026
- D. E. Shaw & Co., Inc. 5.55M sh · $302.07M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- Stephens Investment Management Group LLC 2.71M sh · $147.45M · Q2 2026
- Caligan Partners LP 1.55M sh · $84.51M · Q2 2026
More on 13D Management LLC
FAQ
How long has 13D Management LLC held EXEL?
13D Management LLC has disclosed EXEL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is 13D Management LLC's current position in EXEL?
As of Q2 2026, 13D Management LLC holds 101.33K shares of EXEL (EXELIXIS INC), valued at $5.51M, representing 7.73% of its reported portfolio and ranking #8.
Has 13D Management LLC been buying or selling EXEL?
In the latest 13F filing (Q2 2026), 13D Management LLC held unchanged its position in EXEL.
Which other funds hold EXEL?
Other major institutional holders of EXEL include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Renaissance Technologies, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.